Compound Detail
CHEMBL4471761
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL4471761 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | BLDPQPOUIDGHGL-IBGZPJMESA-N |
2
Targets
6
Activities
1
Assay Types
0
PK Parameters
2
Publications
0
Known Names
Molecular Properties
398.2
MW (Da)
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 6 meas. best 8.09
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Unchecked | IC50 | = | 8.1 | nM | 8.09 | Inhibition of human 20S proteasome beta 5i preincubated for 1 hr followed by flu... | 31283222 |
| Unchecked | IC50 | = | 670.0 | nM | 6.17 | Cytotoxicity against human plasmablasts assessed as reduction in cell viability ... | 31283222 |
| Unchecked | IC50 | = | 2200.0 | nM | 5.66 | Inhibition of human 20S proteasome beta 1i | 31283222 |
| Unchecked | IC50 | = | 2400.0 | nM | 5.62 | Inhibition of 20S proteasome beta 5c (unknown origin) preincubated for 1 hr foll... | 31283222 |
| PBMC | IC50 | = | 5700.0 | nM | 5.24 | Cytotoxicity against human PBMC cells assessed as reduction in cell viability by... | 31283222 |
| Unchecked | IC50 | = | 6000.0 | nM | 5.22 | Cytotoxicity against human pDC assessed as reduction in cell viability by CellTi... | 31283222 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 31283222 | 10.1021/acs.jmedchem.9b00509 | Unchecked | 15 |
| 31283222 | 10.1021/acs.jmedchem.9b00509 | PBMC | 3 |
Data from ChEMBL 36 via Core Engine